Literature DB >> 34641737

Effectiveness of self-financed rotavirus vaccination in Ise City, Japan.

Mitsue Ito1, Masamune Higashigawa1.   

Abstract

In Japan, the herd immunity effect of rotavirus vaccine has not yet been proven. Here, we conducted active surveillance for hospitalization due to rotavirus acute gastroenteritis (AGE) among children under 5 years of age in pre-rotavirus vaccination years and self-financed rotavirus vaccination years to clarify the rotavirus vaccine effectiveness (VE) in reducing hospitalization rates. A time-series analysis showed that the monthly hospitalization rates observed after vaccine introduction were significantly lower than the forecasted hospitalization rates (p < .001, Mann-Whitney U test). In the third year after vaccine introduction, the hospitalization rate declined despite the low vaccination rate of 27-50% for the two preceding years. We estimated four types of VE, namely direct, indirect, total, and overall. The direct VE was calculated from the relative risk ratio of hospitalizations between vaccinated and unvaccinated children. The indirect VE was defined as the population-level effects of vaccination on children not receiving the vaccine. The total VE was defined as the combination of the direct and indirect VE on children receiving the vaccine. The overall VE was determined by the weighted average of indirect VE on the children not receiving the vaccine and the total VE on the children receiving the vaccine. The direct, indirect, total, and overall VE values were calculated as 82% (95% confidence interval, 52-93), 70% (51-82), 95% (87-98), and 86% (77-91), respectively. The high values of indirect, total, and overall VE indicate that the rotavirus vaccine produces a herd immunity effect.

Entities:  

Keywords:  Rotavirus acute gastroenteritis; children; herd effect; rotavirus vaccine; time-series analysis; vaccine coverage; vaccine effectiveness

Mesh:

Substances:

Year:  2021        PMID: 34641737      PMCID: PMC8903919          DOI: 10.1080/21645515.2021.1972706

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   4.526


  20 in total

Review 1.  Herd immunity and herd effect: new insights and definitions.

Authors:  T J John; R Samuel
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

Review 2.  Study designs for evaluating different efficacy and effectiveness aspects of vaccines.

Authors:  M E Halloran; C J Struchiner; I M Longini
Journal:  Am J Epidemiol       Date:  1997-11-15       Impact factor: 4.897

3.  Direct, indirect, total, and overall effectiveness of the rotavirus vaccines for the prevention of gastroenteritis hospitalizations in privately insured US children, 2007-2010.

Authors:  Catherine A Panozzo; Sylvia Becker-Dreps; Virginia Pate; David J Weber; Michele Jonsson Funk; Til Stürmer; M Alan Brookhart
Journal:  Am J Epidemiol       Date:  2014-02-26       Impact factor: 4.897

Review 4.  Rotaviruses: is their surveillance needed?

Authors:  Swapnil Jain; Jitendraa Vashistt; Harish Changotra
Journal:  Vaccine       Date:  2014-04-30       Impact factor: 3.641

5.  Cost-effectiveness analysis of a universal rotavirus immunization program in Japan.

Authors:  Takanori Sato; Toyoko Nakagomi; Osamu Nakagomi
Journal:  Jpn J Infect Dis       Date:  2011       Impact factor: 1.362

6.  Seasonal trend and serotype distribution of rotavirus infection in Japan, 1981-2008.

Authors:  Shuvra K Dey; Hiroshi Ushijima; Outavong Phathammavong; Wisoot Chanit; Shoko Okitsu; Masashi Mizuguchi; Yoshimi Ota
Journal:  Pediatr Infect Dis J       Date:  2010-02       Impact factor: 2.129

7.  Intussusception risk after rotavirus vaccination in U.S. infants.

Authors:  W Katherine Yih; Tracy A Lieu; Martin Kulldorff; David Martin; Cheryl N McMahill-Walraven; Richard Platt; Nandini Selvam; Mano Selvan; Grace M Lee; Michael Nguyen
Journal:  N Engl J Med       Date:  2014-01-14       Impact factor: 91.245

8.  Impact of rotavirus vaccination on the burden of acute gastroenteritis in Nagoya city, Japan.

Authors:  Tetsushi Yoshikawa; Taizo Matsuki; Keiko Sato; Mihoko Mizuno; Motohiro Shibata; Shinji Hasegawa; Makoto Morita; Mitsuji Iwasa; Kusuma Gopala; Katsiaryna Holl
Journal:  Vaccine       Date:  2017-12-13       Impact factor: 3.641

9.  Incidence of childhood primary immune thrombocytopenic purpura.

Authors:  Masamune Higashigawa; Takatoshi Maeyama; Ayako Yoshino; Kazuyuki Matsuda; Mitsue Ito; Tomoaki Maji; Ryouji Ichimi
Journal:  Pediatr Int       Date:  2015-10       Impact factor: 1.524

10.  Sustained reduction in rotavirus-coded hospitalizations in children aged <5 years after introduction of self-financed rotavirus vaccines in Japan.

Authors:  Masayuki Kobayashi; Makoto Miyazaki; Akira Ogawa; Masatoshi Tatsumi
Journal:  Hum Vaccin Immunother       Date:  2019-08-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.